There is however some variability in this trend with respect to individual drugs – notably, in the absence of TLR2 macrophages lost some response to specifically cipro treated infections (Fig. 3C), possibly indicating that cipro treated bacteria natively signal through multiple TLR pathways, and may release more BLPs/peptidoglycan than other cidal treatments. Here, TLR2 is linked to infection.